QR-koodi

A defined method for differentiating human iPSCs into midbrain dopaminergic progenitors that safely restore motor deficits in Parkinson’s disease

BackgroundParkinson’s disease (PD) is a progressive neurodegenerative condition that primarily affects motor functions; it is caused by the loss of midbrain dopaminergic (mDA) neurons. The therapeutic effects of transplanting human-induced pluripotent stem cell (iPSC)-derived mDA neural progenitor c...

Täydet tiedot

Tallennettuna:
Päätekijät: Ryota Nakamura, Risa Nonaka, Genko Oyama, Takayuki Jo, Hikaru Kamo, Maierdanjiang Nuermaimaiti, Wado Akamatsu, Kei-ichi Ishikawa, Nobutaka Hattori
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2023-07-01
Sarja:Frontiers in Neuroscience
Aiheet:
Parkinson’s disease
iPS cells
regenerative medicine
cell transplantation
dopaminergic neurons
Linkit:https://www.frontiersin.org/articles/10.3389/fnins.2023.1202027/full
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia